The Pharmacokinetics of a Hemp-Based Topical Cannabinoid Product in a Sanitized and Controlled Environment

Exclusion criteria

• Non-medical use of psychoactive drugs other than, nicotine, alcohol, or caffeine in the month prior to the screening visit.
• History of or current evidence of significant medical or psychiatric illness judged by the investigator to put the participant at greater risk of experiencing an adverse event due to exposure or completion of other study procedures.
• Current use of medications which, in the opinion of the investigator or medical monitor, will interfere with the study results or the safety of the subject.
• History of xerostomia (dry mouth), or the presence of mucositis, gum infection or bleeding, or other significant oral cavity disease or disorder that in the investigator's opinion may affect the collection of oral fluid samples.
• Known allergy to any ingredients in the study drug.
• Enrolled in another clinical trial or have received any drug as part of a research study within 30 days prior to dosing.